Published in the International Journal of Antimicrobial Agents on March 20, 2020.
Claimed that hydroxychloroquine monotherapy and its combination with azithromycin significantly reduced viral load in COVID-19 patients.
Retracted on December 17, 2024, due to concerns over ethical approval and methodological issues.
Hydroxychloroquine, sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine.
Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda
Azithromycin is an antibiotic medicine.
It's used to treat infections including: chest infections such as pneumonia. ear, nose and throat and nose infections such as sinus infection (sinusitis) skin infections
COMMENTS